Unexplained cholestatic liver tests
Your alkaline phosphatase (ALP) is elevated on a routine liver blood panel and imaging has ruled out a blocked or obstructed bile duct.
AI Summary The AMA (antimitochondrial antibody) test is a blood test used to help diagnose primary biliary cholangitis (PBC), an autoimmune disease that slowly damages the liver's small bile ducts. Doctors order it when alkaline phosphatase is high without a clear cause, often with fatigue or itching. A positive result is read with other liver tests and antibody tests. Treatment centers on long-term ursodeoxycholic acid, with add-on options and symptom care.
Source: www.liverdirectory.com
Medically Reviewed.
The AMA (antimitochondrial antibody) test is a blood test that looks for antibodies your immune system mistakenly makes against mitochondria, the energy-producing structures inside your cells. A positive result is the hallmark finding in primary biliary cholangitis (PBC), an autoimmune disease that slowly damages the small bile ducts inside the liver.
Doctors most often order an AMA test when blood work shows a cholestatic pattern — high alkaline phosphatase — that isn't explained by a blocked bile duct on imaging, especially in a middle-aged woman with fatigue or itching.
This page explains what the AMA test measures, why your doctor might order it, how it fits into the broader autoimmune liver disease panel, what a positive or negative result can mean, and what typically happens next.
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
PBC Antibody Blood Test
The AMA (antimitochondrial antibody) test looks for autoantibodies that target the inner membrane of mitochondria, the structures inside cells that produce energy. In practice, AMA is almost always tested because a doctor suspects primary biliary cholangitis (PBC), formerly called primary biliary cirrhosis — a chronic autoimmune disease in which the immune system attacks and slowly destroys the small bile ducts inside the liver.
PBC causes cholestasis: bile backs up instead of draining normally, which injures liver cells over time and, left untreated, can progress to fibrosis and cirrhosis. AMA is considered PBC's hallmark serologic signature — most people with the disease test positive for it, which makes the AMA test central to reaching a diagnosis without always needing a liver biopsy.
A positive AMA result alone does not confirm PBC. Doctors interpret it together with liver blood tests — especially alkaline phosphatase (ALP) — and, when the picture is unclear, imaging or a liver biopsy to rule out other causes of bile duct injury.
When Doctors Order AMA
Your doctor may order an AMA test in several situations.
Your alkaline phosphatase (ALP) is elevated on a routine liver blood panel and imaging has ruled out a blocked or obstructed bile duct.
You have ongoing fatigue, itchy skin (pruritus), or dry eyes and mouth without an obvious cause — common early signs of PBC.
You are a woman in your 30s to 60s, since PBC most often develops in this group, particularly with a family history of autoimmune disease.
Your doctor wants to distinguish PBC from other causes of liver injury, such as primary sclerosing cholangitis or autoimmune hepatitis, which can look similar early on.
Positive vs. Negative Results
AMA is reported as positive or negative, often with a titer that shows how strong the reaction was.
A single antibody test never stands alone. Your doctor interprets AMA together with alkaline phosphatase, other liver blood tests, and your symptoms before diagnosing PBC.
Autoimmune Liver Panel
Doctors rarely order AMA on its own. It's usually part of a broader panel that helps sort out which autoimmune liver disease, if any, is behind abnormal liver tests.
ANA is a general marker of autoimmune activity. It's positive in many autoimmune diseases, including type 1 autoimmune hepatitis, and in some people with PBC as well.
ASMA usually appears alongside ANA in type 1 autoimmune hepatitis. A positive ASMA with a negative AMA points away from PBC and toward autoimmune hepatitis instead.
PBC often raises IgM specifically, while autoimmune hepatitis tends to raise IgG instead. Checking immunoglobulin levels helps your doctor tell the two conditions apart when antibody results overlap.
A cholestatic pattern — a high alkaline phosphatase with normal or only mildly elevated ALT and AST — is the biochemical fingerprint that, combined with a positive AMA, most strongly supports a PBC diagnosis.
PBC Treatment Overview
Most people are diagnosed with PBC once they have a persistently high alkaline phosphatase together with a positive AMA — guidelines consider this combination enough in typical cases, without a liver biopsy. Biopsy is reserved for atypical cases, such as markedly elevated ALT or suspected overlap with autoimmune hepatitis.
Ursodeoxycholic acid is recommended for essentially all patients with PBC who have abnormal liver enzymes, regardless of how advanced the disease is. It improves bile flow, protects liver cells, and helps slow progression toward fibrosis when taken consistently as a long-term, typically lifelong, therapy. Doctors usually check how well it's working about a year after starting.
For people who don't respond well enough to UDCA, or can't tolerate it, obeticholic acid is an add-on option that works through a different pathway to help regulate bile acids and improve liver enzyme levels.
Itching, fatigue, and dry eyes or mouth are managed separately from the underlying disease. Because cholestasis raises the risk of bone loss, doctors also monitor bone density and typically recommend adequate calcium and vitamin D intake.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
Yes, most experts consider it the single most useful blood marker for PBC. AMA is the hallmark antibody of the disease, and most people with PBC test positive for it. A positive result together with a persistently raised alkaline phosphatase is usually enough to confirm the diagnosis without a liver biopsy. Your doctor will also use imaging to make sure a blocked bile duct is not causing the high alkaline phosphatase. AMA is not perfect. A small share of people with PBC test negative, and AMA can occasionally appear in people without the disease. That is why your doctor reads the result alongside your other liver tests and symptoms.
Yes. A small share of people with PBC never develop a positive AMA. Doctors call this AMA-negative PBC. If your symptoms and liver blood tests still point to PBC, your doctor will not rule it out based on AMA alone. They may order other antibody tests, such as ANA, or imaging to look at the bile ducts. A liver biopsy may also help confirm the diagnosis. A negative AMA makes PBC less likely, but it does not settle the question. Ask your doctor what the rest of your results show.
No. AMA can occasionally appear in people without PBC, including some with other autoimmune conditions and, rarely, people with no liver disease at all. This is why a positive AMA is never read on its own. Your doctor looks at your alkaline phosphatase and other liver blood tests, your symptoms such as fatigue or itching, and sometimes imaging. If the picture is unclear, or if features suggest another condition such as autoimmune hepatitis, a liver biopsy may be recommended. If your AMA is positive but your liver tests are normal, ask your doctor how closely to follow your liver tests over time.
No special preparation is needed. AMA is a simple blood draw. It is often done at the same visit as other liver blood tests. Doctors may also order it as part of an autoimmune liver panel with ANA, ASMA, and immunoglobulin levels, so you may have several tubes of blood drawn at once. Results typically take a few days to come back from the lab. Your doctor will review them with your other liver tests and explain what they mean for you.
PBC has no cure, but medicines can slow it down. Ursodeoxycholic acid (UDCA) is the first-line treatment for people with PBC who have abnormal liver enzymes. It improves bile flow and helps slow progression. It is usually taken long term, often for life. Your doctor will check how well UDCA is working about 12 months after you start. A good response is a strong predictor of better long-term outcomes. If your liver tests stay abnormal, your doctor may add a second-line medicine. Many people with PBC live for decades with a normal life expectancy when the disease is caught and treated early. If the liver is badly damaged, a liver transplant may be considered. Regular follow-up visits help your care team catch changes early.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.